An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis yesterday ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in the disease.

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

WASHINGTON – An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis on April 5 won a prestigious Breakthrough Prize, the award ...